Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on May 10, 2004

Hypertension. 2004
Published online before print May 10, 2004, doi: 10.1161/01.HYP.0000129540.83284.ca
A more recent version of this article appeared on July 1, 2004
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
44/1/42    most recent
01.HYP.0000129540.83284.cav1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, Z.-H.
Right arrow Articles by Mugishima, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, Z.-H.
Right arrow Articles by Mugishima, H.
Related Collections
Right arrow Remodeling
Right arrow Animal models of human disease
Right arrow Growth factors/cytokines
Right arrow Smooth muscle proliferation and differentiation

Submitted on January 26, 2004
Revised on February 24, 2004

Complement 3 Is Involved in the Synthetic Phenotype and Exaggerated Growth of Vascular Smooth Muscle Cells From Spontaneously Hypertensive Rats

Zhi-Hong Lin; Noboru Fukuda*; Xue-Qing Jin; En-Hui Yao; Takahiro Ueno; Morito Endo; Satoshi Saito; Koichi Matsumoto; and Hideo Mugishima

From the Second Department of Internal Medicine (Z.-H.L., N.F., X.-Q.J., E.-H.Y., T.U., M.E., S.S., K.M.) and Department of Advanced Medicine (H.M.), Division of Cell Regeneration and Transplantation, Nihon University School of Medicine, Tokyo, Japan.

* To whom correspondence should be addressed. E-mail: fukudan{at}med.nihon-u.ac.jp.

Abstract--Vascular smooth muscle cells (VSMCs) from spontaneously hypertensive rats (SHR) show the synthetic phenotype and exaggerated growth in comparison with VSMCs from normotensive Wistar-Kyoto (WKY) rats. We investigated genes associated with the synthetic phenotype and exaggerated growth of VSMCs from SHR by microarray. Expression of 1300 transcripts was evaluated by microarray with total mRNA extracted from mid-layer aortic smooth muscle of 3-week-old SHR/Izumo and WKY/Izumo rats. mRNAs encoding sodium-dependent neurotransmitter transporter, epidermal growth factor precursor, EEF2, leptin receptor long-isoform b, clathrin assembly protein short form, and preprocomplement 3 (pre-pro-C3) were expressed only in aortic smooth muscle from SHR by microarray and by reverse-transcription polymerase chain reaction analysis. Pre-pro-C3 mRNA was detected only in cultured VSMCs from SHR. Exogenous C3 changed VSMCs to the synthetic phenotype. Antisense oligodeoxynucleotides (ODN) to C3 reduced the higher level of DNA synthesis in VSMCs from SHR. Antisense ODN to C3 increased expression of SM22{alpha} mRNA and decreased expression of osteopontin and matrix Gla mRNAs. It also decreased expression of growth factor mRNAs in VSMCs from SHR. In conclusion, we have shown that C3, independent of other complement molecules, has direct effects on the phenotype of VSMCs and stimulates growth of these cells. C3 is produced only by VSMCs from SHR. Therefore, C3 may be the gene underlying the synthetic phenotype and exaggerated growth of VSMCs from SHR. C3 may be a new target for the treatment of hypertension.


Key words: hypertrophy • remodeling • rats • muscle, smooth, vascular




This article has been cited by other articles:


Home page
HypertensionHome page
L. Hering, F. Herse, S. Verlohren, J.-K. Park, M. Wellner, F. Qadri, R. Pijnenborg, A. C. Staff, B. Huppertz, D. N. Muller, et al.
Trophoblasts Reduce the Vascular Smooth Muscle Cell Proatherogenic Response
Hypertension, February 1, 2008; 51(2): 554 - 559.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Szeplaki, L. Varga, J. Laki, E. Dosa, S. Rugonfalvi-Kiss, H. O. Madsen, Z. Prohaszka, A. Kocsis, P. Gal, A. Szabo, et al.
Low C1-Inhibitor Levels Predict Early Restenosis After Eversion Carotid Endarterectomy
Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2756 - 2762.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Verdeguer, C. Castro, M. Kubicek, D. Pla, M. Vila-Caballer, A. Vinue, F. Civeira, M. Pocovi, J. J. Calvete, and V. Andres
Complement regulation in murine and human hypercholesterolemia and role in the control of macrophage and smooth muscle cell proliferation
Cardiovasc Res, November 1, 2007; 76(2): 340 - 350.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
N Bjarnegard, C Bengtsson, J Brodszki, G Sturfelt, O Nived, and T Lanne
Increased aortic pulse wave velocity in middle aged women with systemic lupus erythematosus
Lupus, October 1, 2006; 15(10): 644 - 650.
[Abstract] [PDF]


Home page
Physiol. GenomicsHome page
C. J. Sullivan, T. H. Teal, I. P. Luttrell, K. B. Tran, M. A. Peters, and H. Wessells
Microarray analysis reveals novel gene expression changes associated with erectile dysfunction in diabetic rats
Physiol Genomics, October 17, 2005; 23(2): 192 - 205.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. Shagdarsuren, M. Wellner, J.-H. Braesen, J.-K. Park, A. Fiebeler, N. Henke, R. Dechend, P. Gratze, F. C. Luft, and D. N. Muller
Complement Activation in Angiotensin II-Induced Organ Damage
Circ. Res., September 30, 2005; 97(7): 716 - 724.
[Abstract] [Full Text] [PDF]